Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 14;45(7):e1-e3.
doi: 10.1093/jat/bkaa145.

Severe Neurological Sequelae after a Recreational Dose of LSD

Rachel Aakerøy  1 , Wenche Rødseth Brede  1 , Stian Bergseng Stølen  2 , Hege-Merete Krabseth  1 , Lisbeth Solem Michelsen  1 , Trine Naalsund Andreassen  1 , Tiina Ader  3 , Joachim Frost  1   4 , Grete Slettom  5 , Ole Martin Steihaug  6 , Lars Slørdal  4   1
Affiliations

Severe Neurological Sequelae after a Recreational Dose of LSD

Rachel Aakerøy et al. J Anal Toxicol. .

Abstract

A young man with an unremarkable medical history suffered a seizure with subsequent cardiorespiratory arrest and severe neurological sequelae after ingesting a blotter. Analysis of a similar blotter and a serum sample obtained 3 h after the event detected lysergic acid diethylamide (LSD) at an amount of 300 µg in the blotter and at a concentration of 4.0 ng/mL (12.4 nmol/L) in the serum. No other drugs were present in concentrations which may confer significant effects. In addition, no individual traits which would make the patient particularly susceptible to adverse LSD effects have subsequently been identified. This suggests that LSD may confer toxic effects in previously healthy individuals.

PubMed Disclaimer

References

    1. KRIPOS . Narkotika og dopingstatistikk. (2019) https://www.politiet.no/globalassets/04-aktuelt-tall-og-fakta/narkotika/... (Accessed August 13, 2020).
    1. Nichols D.E., Grob C.S. (2018) Is LSD toxic?. Forensic Science International, 284, 141–145. doi: 10.1016/j.forsciint.2018.01.006 - DOI - PubMed
    1. Carbonaro T.M., Gatsch M.B. (2016) Neuropharmacology of N,N-dimethyltryptamine. Brain Research Bulletin, 126, 74–88. doi: 10.1016/j.brainresbull.2016.04.016 - DOI - PMC - PubMed
    1. Vindenes V., Jordbru D., Knapskog A.B., Kvan E., Mathisrud G., Slørdal L., et al. (2012) Impairment based legislative limits for driving under the influence of non-alcohol drugs in Norway. Forensic Science International, 219, 1–11. doi: 10.1016/j.forsciint.2011.11.004 - DOI - PubMed
    1. Nyberg Karlsen S., Spigset O., Slørdal L. (2008) The dark side of ecstasy: Neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine. Basic and Clinical Pharmacology and Toxicology, 102, 15–24. doi: 10.1111/j.1742-7843.2007.00159.x - DOI - PubMed